Antimicrobials, anti-inflammatories, and vaccines were associated with reduced dementia risk, while antipsychotics, antidepressants, and diabetes medications were frequently associated with increased dementia risk.
A multicenter RCT of 87 patients with juvenile idiopathic arthritis-associated uveitis found that discontinuing adalimumab led to significantly higher treatment failure rates compared to continued therapy, though all patients who experienced failure regained control after restarting treatment.
“You are instilling fear into folks who may defer care, who may go without care, whose children may not get the vaccines they need, who may not be able to get treatment for an ear infection or surgery."